Literature DB >> 6355317

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.

K M Boyer, C A Gadzala, P D Kelly, L I Burd, S P Gotoff.   

Abstract

To determine the value of prenatal cultures in defining maternal colonization status at delivery, 5,586 pregnant women were screened at prenatal visits for vaginal and rectal carriage of group B streptococci (GBS). GBS were isolated from 1,272 (22.8%). At delivery, semiquantitative cultures were obtained from 393 prenatal carriers, of whom 264 (67.2%) retained carriage at delivery. Seventeen (8.5%) of 200 women with negative prenatal cultures acquired carriage. The predictive value of a positive prenatal culture was highest (72.5%) in women with prenatal vaginal and rectal colonization and lowest (59.7%) in women with only rectal colonization. The predictive value varied inversely with the interval between prenatal sampling and delivery. In mothers with prenatal carriage, density of colonization at parturition was not predicted by the sites of prenatal colonization. Density of colonization, however, strongly influenced rates of vertical transmission to neonates and rates of heavy infant colonization. Ten infants born to prenatally cultured mothers developed group B streptococcal early-onset disease; the mothers of eight (80%) of the 10 had prenatal colonization with the homologous GBS serotype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6355317     DOI: 10.1093/infdis/148.5.802

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women.

Authors:  E G Gil; M C Rodríguez; R Bartolomé; B Berjano; L Cabero; A Andreu
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions.

Authors:  H D Davies; C E Adair; A Schuchat; D E Low; R S Sauve; A McGeer
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

3.  Evaluation of methods to increase the sensitivity and timeliness of detection of Streptococcus agalactiae in pregnant women.

Authors:  Sue B Overman; Douglas D Eley; Barry E Jacobs; Julie A Ribes
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Infections in international pregnancy study: performance of the optical immunoassay test for detection of group B streptococcus.

Authors:  Jadsada Thinkhamrop; Sompop Limpongsanurak; Mario R Festin; Sean Daly; Anne Schuchat; Pisake Lumbiganon; Elizabeth Zell; Tsungai Chipato; Aye Aye Win; Mindy J Perilla; Jorge E Tolosa; Cynthia G Whitney
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

5.  Rapid screening for Streptococcus agalactiae in vaginal specimens of pregnant women by fluorescent in situ hybridization.

Authors:  Laura A Artz; Volkhard A J Kempf; Ingo B Autenrieth
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

6.  Prevention of perinatal group B streptococcal infection: Management strategies.

Authors:  N N Demianczuk; S A Halperin; D D McMillan
Journal:  Can J Infect Dis       Date:  1997-03

7.  The prevention of early-onset group B streptococcal infections in the newborn.

Authors: 
Journal:  Can J Infect Dis       Date:  1994-11

8.  Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement.

Authors:  S Miyazaki; O Leon; C Panos
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

9.  Assessment of two methods for rapid intrapartum detection of vaginal group B streptococcal colonisation.

Authors:  A J Simpson; J A Mawn; S R Heard
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

10.  Fatal late onset group B streptococcal meningitis following maternal postpartum sepsis.

Authors:  Chantelle Barnard; Mort Goldbach; Hilary Whyte; Lee Ford-Jones; Susan King
Journal:  Paediatr Child Health       Date:  2003-09       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.